CannaPharmaRx, Inc. (CPMD) stock

CPMDOTCPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 18, 2026Score 2/30

$0.00+0.00 (0.00%)

Close on Oct 16, 2026Market cap $1.36MP/E –Yield –

CannaPharmaRx r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2014 it was $324.15K.

Period	Period end	Value	Change
FY2014	Dec 31, 2014	$324.15K	–

Parsed from the XBRL in CannaPharmaRx's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-10 reverse split on Nov 10, 2006
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CPMD.

Revenue growth24.8% · median 3829.0%

Gross margin-88.8% · median 50.2%

Net margin-666.2% · median -175.2%

Advertisement
300 × 250

See a number that looks wrong?